Publications by authors named "J L Nadler"

This systematic review aimed to identify and describe best practice for the intraoperative anesthetic management of patients undergoing emergent/urgent decompressive craniotomy or craniectomy for any indication. The PubMed, Scopus, EMBASE, and Cochrane databases were searched for articles related to urgent/emergent craniotomy/craniectomy for intracranial hypertension or brain herniation. Only articles focusing on intraoperative anesthetic management were included; those investigating surgical or intensive care unit management were excluded.

View Article and Find Full Text PDF

The semi-aquatic North American river otter (Lontra canadensis) has the unique challenge of navigating slippery algae-coated rocks. Unlike other river otter species, each rear paw of the North American river otter has a series of soft, circular, and keratinized plantar pads similar to the felt pads on the boots of fly fishermen. Surrounding these soft pads is a textured epidermal layer.

View Article and Find Full Text PDF

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing β cells and involves an interplay between β cells and cells of the innate and adaptive immune systems. We investigated the therapeutic potential of targeting 12-lipoxygenase (12-LOX), an enzyme implicated in inflammatory pathways in β cells and macrophages, using a mouse model in which the endogenous mouse Alox15 gene is replaced by the human ALOX12 gene. Our finding demonstrated that VLX-1005, a potent 12-LOX inhibitor, effectively delayed the onset of autoimmune diabetes in human gene replacement non-obese diabetic mice.

View Article and Find Full Text PDF
Article Synopsis
  • - Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin-producing β cells, and the study explores the role of the enzyme 12-lipoxygenase (12-LOX) in this process.
  • - Researchers tested a 12-LOX inhibitor, VLX-1005, on a mouse model that has a human gene replacement, finding it delays the onset of autoimmune diabetes while reducing immune cell infiltration and enhancing immune suppression.
  • - Further analysis showed that VLX-1005 treatment changed inflammatory pathways, decreasing immune responses and supporting its potential as a therapy for T1D through modulation of the immune environment in the pancreas.
View Article and Find Full Text PDF

Splenic leukocytes, particularly macrophage-expressed lipoxygenases, facilitate the biosynthesis of resolution mediators essential for cardiac repair. Next, we asked whether deletion of 12/15 lipoxygenase (12/15LOX) in macrophages impedes the resolution of inflammation following myocardial infarction (MI). Using 12/15flox/flox and LysMcre scheme, we generated macrophage-specific 12/15LOX (Mɸ-12/15LOX-/-) mice.

View Article and Find Full Text PDF